4.6 Article

Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study

期刊

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2021.09.002

关键词

Ad26.COV2.S; AZD1222; BNT162b2; bullous pemphigoid; chilblains; COVID-19; delayed large local; dermal hypersensitivity reaction; dermatology; dermatopathology; erythema multiforme; erythromelalgia; Johnson & Johnson Janssen; lichen planus; Moderna; morbilliform; mRNA-1273; Oxford-AstraZeneca; papular; papulosquamous; pathology; pernio; Pfizer-BioNTech; pityriasis rosea; psoriasis; registry; SARS-CoV-2; Stevens-Johnson syndrome; urticaria; vaccine; zoster

资金

  1. International League of Dermatological Societies
  2. American Academy of Dermatology

向作者/读者索取更多资源

This study investigated histopathologic features and clinical correlations of cutaneous reactions after COVID-19 vaccination, proposing the concept of V-REPP (vaccine-related eruption of papules and plaques) and 12 other reaction patterns. Despite limitations in available biopsy reports, the research provided new insights into skin reactions following vaccination.
Background: Cutaneous reactions after COV1D-19 vaccination have been commonly reported; however, histopathologic features and clinical correlations have not been well characterized. Methods: We evaluated for a history of skin biopsy all reports of reactions associated with COVID-19 vaccination identified in an international registry. When histopathology reports were available, we categorized them by reaction patterns. Results: Of 803 vaccine reactions reported, 58 (7%) cases had biopsy reports available for review. The most common histopathologic reaction pattern was spongiotic dermatitis, which clinically ranged from robust papules with overlying crust, to pityriasis rosea-like eruptions, to pink papules with fine scale. We propose the acronym V-REPP (vaccine-related eruption of papules and plaques) for this spectrum. Other clinical patterns included bullous pemphigoid-like (n = 12), dermal hypersensitivity (n = 4), herpes zoster (n = 4), lichen planus-like (n = 4), pernio (n = 3), urticarial (n = 2), neutrophilic dermatosis (n = 2), leukocytoclastic vasculitis (n = 2), morbilliform (n = 2), delayed large local reactions (n = 2), erythromelalgia (n = 1), and other (n = 5). Limitations: Cases in which histopathology was available represented a minority of registry entries. Analysis of registry data cannot measure incidence. Conclusion: Clinical and histopathologic correlation allowed for categorization of cutaneous reactions to the COVID-19 vaccine. We propose defining a subset of vaccine-related eruption of papules and plaques, as well as 12 other patterns, following COVID-19 vaccination.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据